Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ALNYALNYLAM PHARMACEUTICALS, INC.

Nasdaq · CIK 0001178670
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts456

Identity from submissions API

NameALNYLAM PHARMACEUTICALS, INC.
CIK0001178670
TickersALNY
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN770602661
LEI—
Fiscal year end1231
State of incorporation—
Phone(617) 551-8200
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)1

Former names

  • ALNYLAM PHARMACEUTICALS INC (2002-07-09T04:00:00.000Z → 2004-07-02T04:00:00.000Z)
Business address
675 WEST KENDALL STREET
HENRI A. TERMEER SQUARE
CAMBRIDGE
MA
02142
MA
Mailing address
675 WEST KENDALL STREET
HENRI A. TERMEER SQUARE
CAMBRIDGE
MA
02142
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1692 filing rows loaded from submissions recent; extra archives: CIK0001178670-submissions-001.json (692 filings, 2002-07-09 to 2014-10-08).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-17 4 PRIMARY DOCUMENT 0001178670-26-000091 5905
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001897612-26-000726 005-79884 261556524 34 7725
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001422848-26-000134 005-79884 261553926 34 7704
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001422849-26-000177 005-79884 261551049 34 7645
2026-11-12 4 PRIMARY DOCUMENT 0001178670-26-000089 7749
2026-11-12 4 PRIMARY DOCUMENT 0001178670-26-000087 5425
2026-11-12 4 PRIMARY DOCUMENT 0001178670-26-000085 4555
2026-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002695 005-79884 261526096 34 11988
2026-11-05 8-K 8-K 5.02,8.01 0001178670-26-000080 001-36407 261524833 34 152484 1 1
2026-10-30 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100121-26-001039 005-79884 261506861 34 7463
2026-10-29 10-Q 10-Q 0001178670-26-000076 001-36407 261497680 34 11499905 1 1
2026-10-29 8-K 8-K 2.02,9.01 0001178670-26-000074 001-36407 261497657 34 513495 1 1
2026-10-06 4 PRIMARY DOCUMENT 0001178670-26-000068 4973
2026-10-02 144 xsl144X01/primary_doc.xml 0001959173-26-007216 001-36407 261436046 33 4633
2026-09-22 4 PRIMARY DOCUMENT 0001178670-26-000065 6110
2026-07-30 10-Q 10-Q 0001178670-26-000062 001-36407 261220304 34 11125755 1 1
2026-07-30 8-K 8-K 2.02,9.01 0001178670-26-000060 001-36407 261220294 34 515639 1 1
2026-06-03 4 PRIMARY DOCUMENT 0001178670-26-000048 17011
2026-06-03 4 PRIMARY DOCUMENT 0001178670-26-000047 5418
2026-06-03 3 PRIMARY DOCUMENT 0001178670-26-000046 7186
2026-06-01 144 xsl144X01/primary_doc.xml 0001969223-26-000618 001-36407 261051253 33 4565
2026-05-27 8-K 8-K 5.02,5.07 0001628280-26-038499 001-36407 261026646 34 166775 1 1
2026-05-22 4 PRIMARY DOCUMENT 0001178670-26-000042 8495
2026-05-22 4 PRIMARY DOCUMENT 0001178670-26-000041 7630
2026-05-22 4 PRIMARY DOCUMENT 0001178670-26-000040 7622
2026-05-22 4 PRIMARY DOCUMENT 0001178670-26-000039 8502
2026-05-22 4 PRIMARY DOCUMENT 0001178670-26-000038 7676
2026-05-22 4 PRIMARY DOCUMENT 0001178670-26-000037 7616
2026-05-22 4 PRIMARY DOCUMENT 0001178670-26-000036 7630
2026-05-22 4 PRIMARY DOCUMENT 0001178670-26-000035 8496
2026-05-22 4 PRIMARY DOCUMENT 0001178670-26-000034 7628
2026-05-14 4 PRIMARY DOCUMENT 0001178670-26-000017 6879
2026-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001422849-26-000061 005-79884 26977678 34 7657
2026-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001422848-26-000050 005-79884 26976424 34 7679
2026-05-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001107 005-79884 26946559 34 11610
2026-04-30 10-Q 10-Q 0001628280-26-028605 001-36407 26920246 34 8966268 1 1
2026-04-30 8-K 8-K 2.02,9.01 0001628280-26-028601 001-36407 26920191 34 479344 1 1
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-000160 005-79884 26917224 34 7496
2026-04-07 4 PRIMARY DOCUMENT 0001178670-26-000014 29618
2026-04-07 3 PRIMARY DOCUMENT 0001178670-26-000012 9915
2026-04-06 ARS ARS 0001140361-26-013365 001-36407 26841993 34 39247914
2026-04-06 DEFA14A DEFA14A 0001628280-26-023924 001-36407 26841658 34 866239
2026-04-06 DEF 14A DEF 14A 0001628280-26-023923 001-36407 26841639 34 33822931 1 1
2026-04-06 144 xsl144X01/primary_doc.xml 0001969223-26-000425 001-36407 26841183 33 4559
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000562 005-79884 26797551 34 7260
2026-03-06 4 PRIMARY DOCUMENT 0001735276-26-000063 27590
2026-03-06 4 PRIMARY DOCUMENT 0001735276-26-000062 19066
2026-03-06 4 PRIMARY DOCUMENT 0001735276-26-000061 19070
2026-03-06 4 PRIMARY DOCUMENT 0001735276-26-000060 18123
2026-03-06 4 PRIMARY DOCUMENT 0001735276-26-000059 26528
2026-03-05 144 xsl144X01/primary_doc.xml 0001969223-26-000296 001-36407 26726048 33 6513
2026-03-05 144 xsl144X01/primary_doc.xml 0001969223-26-000295 001-36407 26726029 33 5834
2026-03-04 4 PRIMARY DOCUMENT 0001735276-26-000053 27009
2026-03-04 4 PRIMARY DOCUMENT 0001735276-26-000052 35526
2026-03-04 4 PRIMARY DOCUMENT 0001735276-26-000051 34469
2026-03-04 4 PRIMARY DOCUMENT 0001735276-26-000050 26059
2026-03-04 4 PRIMARY DOCUMENT 0001735276-26-000049 7583
2026-03-04 4 PRIMARY DOCUMENT 0001735276-26-000048 29980
2026-03-04 8-K 8-K 5.02 0001628280-26-014728 001-36407 26722777 34 156944 1 1
2026-03-03 144 xsl144X01/primary_doc.xml 0001969223-26-000276 001-36407 26715665 33 6368
2026-03-03 144 xsl144X01/primary_doc.xml 0001969223-26-000273 001-36407 26714173 33 5692
2026-03-02 4 PRIMARY DOCUMENT 0001735276-26-000041 8419
2026-03-02 4 PRIMARY DOCUMENT 0001735276-26-000040 8422
2026-03-02 4 PRIMARY DOCUMENT 0001735276-26-000039 7477
2026-03-02 4 PRIMARY DOCUMENT 0001735276-26-000038 18332
2026-02-27 144 xsl144X01/primary_doc.xml 0001969223-26-000253 001-36407 26699565 33 5046
2026-02-25 4 PRIMARY DOCUMENT 0001735276-26-000032 6104
2026-02-17 4 PRIMARY DOCUMENT 0001735276-26-000029 9358
2026-02-17 4 PRIMARY DOCUMENT 0001735276-26-000028 8293
2026-02-17 4 PRIMARY DOCUMENT 0001735276-26-000027 7351
2026-02-17 4 PRIMARY DOCUMENT 0001735276-26-000026 10290
2026-02-17 4 PRIMARY DOCUMENT 0001735276-26-000025 8296
2026-02-17 144 xsl144X01/primary_doc.xml 0001969223-26-000186 001-36407 26641229 33 5865
2026-02-12 S-8 S-8 0001628280-26-007687 333-293419 26626421 33 243155 1 1
2026-02-12 10-K 10-K 0001628280-26-007497 001-36407 26623520 34 17731961 1 1
2026-02-12 8-K 8-K 2.02,9.01 0001628280-26-007491 001-36407 26623503 34 601998 1 1
2026-01-14 4 PRIMARY DOCUMENT 0001735276-26-000015 44940
2026-01-14 4 PRIMARY DOCUMENT 0001735276-26-000014 43890
2026-01-14 4 PRIMARY DOCUMENT 0001735276-26-000013 43881
2026-01-14 4 PRIMARY DOCUMENT 0001735276-26-000012 42929
2026-01-14 4 PRIMARY DOCUMENT 0001735276-26-000011 54990
2026-01-13 144 xsl144X01/primary_doc.xml 0001969223-26-000038 001-36407 26530465 33 5213
2026-01-12 8-K 8-K 2.02 0001628280-26-001755 001-36407 26524668 34 235347 1 1
2026-01-07 4 PRIMARY DOCUMENT 0001735276-26-000005 5378
2026-01-07 3 PRIMARY DOCUMENT 0001735276-26-000004 7244
2025-12-11 8-K 8-K 8.01,9.01 0001193125-25-315047 001-36407 251563514 34 166024 1 1
2025-12-03 8-K 8-K 5.02 0001628280-25-055084 001-36407 251547099 34 184367 1 1
2025-12-01 4 PRIMARY DOCUMENT 0001735276-25-000125 19540
2025-11-19 4 PRIMARY DOCUMENT 0001735276-25-000123 27181
2025-11-17 144 xsl144X01/primary_doc.xml 0001969223-25-000959 001-36407 251491051 33 5603
2025-11-14 4 PRIMARY DOCUMENT 0001735276-25-000120 50794
2025-11-12 144 xsl144X01/primary_doc.xml 0001969223-25-000940 001-36407 251472513 33 4645
2025-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002664 005-79884 251452546 34 11903
2025-10-30 10-Q 10-Q 0001628280-25-047345 001-36407 251432350 34 10085918 1 1
2025-10-30 8-K 8-K 2.02,9.01 0001628280-25-047342 001-36407 251432320 34 521316 1 1
2025-10-03 4 PRIMARY DOCUMENT 0001735276-25-000118 5134
2025-10-03 4 PRIMARY DOCUMENT 0001735276-25-000117 29609
2025-10-03 4 PRIMARY DOCUMENT 0001735276-25-000116 29611
2025-10-03 4 PRIMARY DOCUMENT 0001735276-25-000115 26664
2025-10-03 4 PRIMARY DOCUMENT 0001735276-25-000114 29620
2025-10-03 4 PRIMARY DOCUMENT 0001735276-25-000113 39954
2025-10-03 8-K 8-K 1.01,2.03,9.01 0001193125-25-230201 001-36407 251374038 34 1476038 1 1
2025-10-03 144 xsl144X01/primary_doc.xml 0001969223-25-000830 001-36407 251373836 33 5187
2025-09-22 3 PRIMARY DOCUMENT 0001735276-25-000105 7277
2025-09-12 8-K 8-K 1.01,2.03,3.02,8.01,9.01 0001193125-25-202366 001-36407 251312409 34 1284021 1 1
2025-09-11 4 PRIMARY DOCUMENT 0001735276-25-000097 35683
2025-09-10 8-K 8-K 8.01,9.01 0001193125-25-199686 001-36407 251304670 34 193889 1 1
2025-09-09 144 xsl144X01/primary_doc.xml 0001969223-25-000750 001-36407 251303207 33 4575
2025-09-02 4 PRIMARY DOCUMENT 0001735276-25-000094 14344
2025-08-29 144 xsl144X01/primary_doc.xml 0001969223-25-000686 001-36407 251280788 33 5053
2025-08-19 4 PRIMARY DOCUMENT 0001735276-25-000092 32896
2025-08-19 4 PRIMARY DOCUMENT 0001735276-25-000091 20178
2025-08-19 4 PRIMARY DOCUMENT 0001735276-25-000090 21126
2025-08-19 4 PRIMARY DOCUMENT 0001735276-25-000089 21128
2025-08-19 4 PRIMARY DOCUMENT 0001735276-25-000088 21137
2025-08-19 4 PRIMARY DOCUMENT 0001735276-25-000087 9279
2025-08-19 144 xsl144X01/primary_doc.xml 0001969223-25-000634 001-36407 251231695 33 4538
2025-08-18 144 xsl144X01/primary_doc.xml 0001969223-25-000627 001-36407 251227989 33 4575
2025-08-15 4 PRIMARY DOCUMENT 0001735276-25-000079 45821
2025-08-14 144 xsl144X01/primary_doc.xml 0001969223-25-000610 001-36407 251219446 33 4579
2025-07-31 10-Q 10-Q 0001178670-25-000090 001-36407 251169534 34 8824525 1 1
2025-07-31 8-K 8-K 2.02,9.01 0001178670-25-000089 001-36407 251169517 34 500400 1 1
2025-07-02 4 PRIMARY DOCUMENT 0001735276-25-000077 6108
2025-06-18 8-K 8-K 5.02 0001178670-25-000076 001-36407 251057552 34 175673 1 1
2025-06-17 UPLOAD filename1.pdf 0000000000-25-006335 001-36407 39817
2025-06-03 4 PRIMARY DOCUMENT 0001735276-25-000075 22673
2025-06-02 144 xsl144X01/primary_doc.xml 0001969223-25-000378 001-36407 251015009 33 5300
2025-05-30 144 xsl144X01/primary_doc.xml 0001969223-25-000372 001-36407 251011219 33 4644
2025-05-30 144 xsl144X01/primary_doc.xml 0001969223-25-000370 001-36407 251010994 33 4720
2025-05-22 CORRESP filename1.htm 0001178670-25-000069 567027
2025-05-19 4 PRIMARY DOCUMENT 0001735276-25-000072 33444
2025-05-19 4 PRIMARY DOCUMENT 0001735276-25-000071 5877
2025-05-15 144 xsl144X01/primary_doc.xml 0001969223-25-000313 001-36407 25952519 33 4527
2025-05-13 8-K 8-K 5.03,5.07 0001178670-25-000062 001-36407 25941144 34 195397 1 1
2025-05-12 4 PRIMARY DOCUMENT 0001735276-25-000068 8445
2025-05-12 4 PRIMARY DOCUMENT 0001735276-25-000067 8412
2025-05-12 4 PRIMARY DOCUMENT 0001735276-25-000066 7577
2025-05-12 4 PRIMARY DOCUMENT 0001735276-25-000065 7557
2025-05-12 4 PRIMARY DOCUMENT 0001735276-25-000064 7631
2025-05-12 4 PRIMARY DOCUMENT 0001735276-25-000063 8423
2025-05-12 4 PRIMARY DOCUMENT 0001735276-25-000062 11637
2025-05-12 4 PRIMARY DOCUMENT 0001735276-25-000061 7566
2025-05-12 4 PRIMARY DOCUMENT 0001735276-25-000060 8391
2025-05-12 4 PRIMARY DOCUMENT 0001735276-25-000059 7520
2025-05-09 UPLOAD filename1.pdf 0000000000-25-004975 001-36407 44732
2025-05-06 4 PRIMARY DOCUMENT 0001735276-25-000047 5878
2025-05-01 10-Q 10-Q 0001178670-25-000052 001-36407 25899598 34 8033827 1 1
2025-05-01 8-K 8-K 9.01 0001178670-25-000050 001-36407 25899546 34 462902 1 1
2025-04-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000378 005-79884 25816981 34 6306
2025-04-04 DEFA14A DEFA14A 0001178670-25-000044 001-36407 25815168 34 41326
2025-03-25 4 PRIMARY DOCUMENT 0001735276-25-000041 11873
2025-03-25 4 PRIMARY DOCUMENT 0001735276-25-000040 9341
2025-03-24 ARS ARS 0001193125-25-061427 001-36407 25764961 34 58724176
2025-03-24 DEFA14A DEFA14A 0001193125-25-061424 001-36407 25764934 34 1054123
2025-03-24 DEF 14A DEF 14A 0001178670-25-000040 001-36407 25764682 34 29376929 1 1
2025-03-24 144 xsl144X01/primary_doc.xml 0001973141-25-000167 001-36407 25764318 33 4547
2025-03-24 144 xsl144X01/primary_doc.xml 0001973141-25-000163 001-36407 25764187 33 7840
2025-03-21 144 xsl144X01/primary_doc.xml 0001973141-25-000162 001-36407 25760412 33 7678
2025-03-21 8-K 8-K 8.01 0001178670-25-000038 001-36407 25758030 34 224665 1 1
2025-03-14 4 PRIMARY DOCUMENT 0001735276-25-000037 6960
2025-03-14 PRE 14A PRE 14A 0001178670-25-000035 001-36407 25740207 34 29413407 1 1
2025-03-05 8-K 8-K 5.02 0001178670-25-000031 001-36407 25711747 34 177215 1 1
2025-03-05 4 PRIMARY DOCUMENT 0001735276-25-000035 7610
2025-03-05 4 PRIMARY DOCUMENT 0001735276-25-000034 33702
2025-03-05 4 PRIMARY DOCUMENT 0001735276-25-000033 19217
2025-03-05 4 PRIMARY DOCUMENT 0001735276-25-000032 35594
2025-03-05 4 PRIMARY DOCUMENT 0001735276-25-000031 21522
2025-03-05 4 PRIMARY DOCUMENT 0001735276-25-000030 21566
2025-03-04 144 xsl144X01/primary_doc.xml 0001973141-25-000126 001-36407 25704318 33 5762
2025-03-04 144 xsl144X01/primary_doc.xml 0001973141-25-000125 001-36407 25704290 33 7188
2025-03-03 4 PRIMARY DOCUMENT 0001735276-25-000023 23151
2025-03-03 4 PRIMARY DOCUMENT 0001735276-25-000022 23109
2025-03-03 4 PRIMARY DOCUMENT 0001735276-25-000021 22204
2025-03-03 4 PRIMARY DOCUMENT 0001735276-25-000020 24258
2025-03-03 4 PRIMARY DOCUMENT 0001735276-25-000019 19193
2025-03-03 144 xsl144X01/primary_doc.xml 0001973141-25-000120 001-36407 25697957 33 6540
2025-03-03 144 xsl144X01/primary_doc.xml 0001973141-25-000119 001-36407 25697937 33 5169
2025-02-18 4 PRIMARY DOCUMENT 0001735276-25-000012 27638
2025-02-18 4 PRIMARY DOCUMENT 0001735276-25-000011 27603
2025-02-18 4 PRIMARY DOCUMENT 0001735276-25-000010 35668
2025-02-18 4 PRIMARY DOCUMENT 0001735276-25-000009 39012
2025-02-18 144 xsl144X01/primary_doc.xml 0001973141-25-000098 001-36407 25635046 33 5882
2025-02-18 144 xsl144X01/primary_doc.xml 0001973141-25-000097 001-36407 25635019 33 5169
2025-02-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001422848-25-000022 005-79884 25619279 34 7416
2025-02-13 10-K 10-K 0001178670-25-000026 001-36407 25617356 34 14466651 1 1
2025-02-13 8-K 8-K 9.01 0001178670-25-000020 001-36407 25617293 34 541777 1 1
2025-01-29 4 PRIMARY DOCUMENT 0001735276-25-000004 14273
2025-01-27 144 xsl144X01/primary_doc.xml 0001973141-25-000045 001-36407 25558813 33 6804
2025-01-24 4 PRIMARY DOCUMENT 0001735276-25-000002 9715
2025-01-23 144 xsl144X01/primary_doc.xml 0001973141-25-000035 001-36407 25550352 33 4726
2025-01-13 8-K 8-K 2.02 0001178670-25-000008 001-36407 25524813 34 212948 1 1
2024-12-13 4 PRIMARY DOCUMENT 0001735276-24-000110 16963
2024-12-12 144 xsl144X01/primary_doc.xml 0001973141-24-000609 001-36407 241544842 33 4587
2024-11-27 4 PRIMARY DOCUMENT 0001735276-24-000108 15866
2024-11-27 4 PRIMARY DOCUMENT 0001735276-24-000107 16974
2024-11-27 4 PRIMARY DOCUMENT 0001735276-24-000106 15827
2024-11-27 4 PRIMARY DOCUMENT 0001735276-24-000105 14926
2024-11-27 4 PRIMARY DOCUMENT 0001735276-24-000104 22912
2024-11-27 144 xsl144X01/primary_doc.xml 0001973141-24-000581 001-36407 241511071 33 4575
2024-11-12 SC 13G/A filing.txt 0000315066-24-002658 005-79884 241444427 34 8490
2024-11-08 SC 13G/A SEC SCHEDULE 13G 0000902219-24-000383 005-79884 241438506 34 32199
2024-10-31 10-Q 10-Q 0001178670-24-000053 001-36407 241412575 34 9607084 1 1
2024-10-31 8-K 8-K 9.01 0001178670-24-000052 001-36407 241412544 34 483797 1 1
2024-10-10 4 PRIMARY DOCUMENT 0001735276-24-000098 7200
2024-10-03 4 PRIMARY DOCUMENT 0001735276-24-000096 5172
2024-10-03 3 PRIMARY DOCUMENT 0001735276-24-000095 7328
2024-09-25 UPLOAD filename1.pdf 0000000000-24-010900 001-36407 39895
2024-08-22 4 PRIMARY DOCUMENT 0001735276-24-000085 9397
2024-08-22 CORRESP filename1.htm 0001178670-24-000048 454842
2024-08-20 144 xsl144X01/primary_doc.xml 0001973141-24-000418 001-36407 241226150 33 5895
2024-08-14 4 PRIMARY DOCUMENT 0001735276-24-000083 22092
2024-08-12 144 xsl144X01/primary_doc.xml 0001973141-24-000409 001-36407 241196795 33 5109
2024-08-12 SC 13G/A filing.txt 0000315066-24-001883 005-79884 241195245 34 8286
2024-08-12 UPLOAD filename1.pdf 0000000000-24-009192 001-36407 44170
2024-08-08 4 PRIMARY DOCUMENT 0001735276-24-000080 24265
2024-08-06 144 xsl144X01/primary_doc.xml 0001973141-24-000397 001-36407 241179213 33 4586
2024-08-02 4 PRIMARY DOCUMENT 0001735276-24-000077 9374
2024-08-01 144 xsl144X01/primary_doc.xml 0001973141-24-000378 001-36407 241166430 33 5242
2024-08-01 10-Q 10-Q 0001178670-24-000041 001-36407 241164509 34 10753164 1 1
2024-08-01 8-K 8-K 9.01 0001178670-24-000039 001-36407 241164472 34 486691 1 1
2024-07-12 4 PRIMARY DOCUMENT 0001735276-24-000075 5788
2024-07-11 144 xsl144X01/primary_doc.xml 0001973141-24-000348 001-36407 241112467 33 4594
2024-07-05 SC 13G/A alnylam28062024.txt 0001088875-24-000081 005-79884 241101862 34 10950
2024-06-27 4 PRIMARY DOCUMENT 0001735276-24-000072 8437
2024-06-26 4 PRIMARY DOCUMENT 0001735276-24-000070 19253
2024-06-26 4 PRIMARY DOCUMENT 0001735276-24-000069 29632
2024-06-26 4 PRIMARY DOCUMENT 0001735276-24-000068 28524
2024-06-26 4 PRIMARY DOCUMENT 0001735276-24-000067 28482
2024-06-26 4 PRIMARY DOCUMENT 0001735276-24-000066 27579
2024-06-26 4 PRIMARY DOCUMENT 0001735276-24-000065 28540
2024-06-25 144 xsl144X01/primary_doc.xml 0001973141-24-000323 001-36407 241069075 33 5234
2024-06-24 144 xsl144X01/primary_doc.xml 0001973141-24-000319 001-36407 241064211 33 4557
2024-05-31 4 PRIMARY DOCUMENT 0001735276-24-000058 12162
2024-05-29 144 xsl144X01/primary_doc.xml 0001973141-24-000274 001-36407 24998231 33 4585
2024-05-20 8-K 8-K 5.07 0001178670-24-000027 001-36407 24965127 34 172977 1 1
2024-05-20 4 PRIMARY DOCUMENT 0001735276-24-000055 9709
2024-05-20 4 PRIMARY DOCUMENT 0001735276-24-000054 9802
2024-05-20 4 PRIMARY DOCUMENT 0001735276-24-000053 9712
2024-05-20 4 PRIMARY DOCUMENT 0001735276-24-000052 9711
2024-05-20 4 PRIMARY DOCUMENT 0001735276-24-000051 9758
2024-05-20 4 PRIMARY DOCUMENT 0001735276-24-000050 9734
2024-05-20 4 PRIMARY DOCUMENT 0001735276-24-000049 9691
2024-05-20 4 PRIMARY DOCUMENT 0001735276-24-000048 9688
2024-05-20 4 PRIMARY DOCUMENT 0001735276-24-000047 9728
2024-05-20 4 PRIMARY DOCUMENT 0001735276-24-000046 9750
2024-05-20 4 PRIMARY DOCUMENT 0001735276-24-000045 9874
2024-05-02 10-Q 10-Q 0001178670-24-000023 001-36407 24905466 34 9295002 1 1
2024-05-02 8-K 8-K 9.01 0001178670-24-000021 001-36407 24905453 34 441287 1 1
2024-04-01 ARS ARS 0001193125-24-083479 001-36407 24810075 34 3489943
2024-04-01 DEFA14A DEFA14A 0001193125-24-083471 001-36407 24810011 34 935429
2024-04-01 DEF 14A DEF 14A 0001193125-24-083454 001-36407 24809904 34 4927349 1 1
2024-03-28 3 PRIMARY DOCUMENT 0001735276-24-000033 14690
2024-03-05 4 PRIMARY DOCUMENT 0001735276-24-000030 7950
2024-03-05 4 PRIMARY DOCUMENT 0001735276-24-000029 9999
2024-03-05 4 PRIMARY DOCUMENT 0001735276-24-000028 8856
2024-03-05 4 PRIMARY DOCUMENT 0001735276-24-000027 8894
2024-03-04 8-K 8-K 5.02,9.01 0001193125-24-057906 001-36407 24715361 34 223297 1 1
2024-03-01 4 PRIMARY DOCUMENT 0001735276-24-000022 19073
2024-02-29 4 PRIMARY DOCUMENT 0001735276-24-000020 16204
2024-02-29 4 PRIMARY DOCUMENT 0001735276-24-000019 17111
2024-02-29 4 PRIMARY DOCUMENT 0001735276-24-000018 17149
2024-02-29 4 PRIMARY DOCUMENT 0001735276-24-000017 18252
2024-02-29 4 PRIMARY DOCUMENT 0001735276-24-000016 16454
2024-02-29 144 xsl144X01/primary_doc.xml 0001973141-24-000138 001-36407 24703405 33 4726
2024-02-20 4 PRIMARY DOCUMENT 0001735276-24-000010 13105
2024-02-20 4 PRIMARY DOCUMENT 0001735276-24-000009 11962
2024-02-20 4 PRIMARY DOCUMENT 0001735276-24-000008 11057
2024-02-20 4 PRIMARY DOCUMENT 0001735276-24-000007 12000
2024-02-15 10-K 10-K 0001178670-24-000008 001-36407 24644159 34 13966369 1 1
2024-02-15 8-K ALNYLAM PHARMACEUTICALS, INC. 8-K 2.02,9.01 0001157523-24-000253 001-36407 24642207 34 783990 1 1
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020232 005-79884 24627499 34 13213
2024-02-09 SC 13G/A SEC SCHEDULE 13G 0001422848-24-000213 005-79884 24616704 34 18461
2024-02-09 SC 13G/A SEC SCHEDULE 13G 0000902219-24-000264 005-79884 24611424 34 38189
2024-02-09 SC 13G/A filing.txt 0000315066-24-001006 005-79884 24611380 34 8487
2024-02-05 4 PRIMARY DOCUMENT 0001735276-24-000002 13001
2024-01-29 SC 13G/A alnylam29122023.txt 0001088875-24-000047 005-79884 24571888 34 11385
2024-01-26 SC 13G/A us02043q1076_012624.txt 0001086364-24-004819 005-79884 24569160 34 13998
2024-01-19 8-K 8-K 5.02,9.01 0001193125-24-011278 001-36407 24546012 34 145803 1 1
2024-01-08 8-K FORM 8-K 2.02,9.01 0001193125-24-003854 001-36407 24518273 34 180022 1 1
2023-12-29 4 PRIMARY DOCUMENT 0001735276-23-000081 9207
2023-12-27 144 xsl144X01/primary_doc.xml 0001973141-23-000369 001-36407 231517972 33 4544
2023-12-11 144 xsl144X01/primary_doc.xml 0001973141-23-000333 001-36407 231478189 33 4453
2023-11-02 10-Q 10-Q 0001178670-23-000023 001-36407 231370227 34 10534380 1 1
2023-11-02 8-K ALNYLAM PHARMACEUTICALS, INC. 8-K 2.02,9.01 0001157523-23-001622 001-36407 231370194 34 693207 1 1
2023-10-10 8-K 8-K 8.01,9.01 0001193125-23-253084 001-36407 231315650 34 190461 1 1
2023-09-28 8-K 8-K 5.02 0001193125-23-245768 001-36407 231290651 34 144905 1 1
2023-08-07 4 PRIMARY DOCUMENT 0001735276-23-000079 26207
2023-08-07 4 PRIMARY DOCUMENT 0001735276-23-000078 19443
2023-08-07 4 PRIMARY DOCUMENT 0001735276-23-000077 19480
2023-08-07 4 PRIMARY DOCUMENT 0001735276-23-000076 19721
2023-08-07 144 xsl144X01/primary_doc.xml 0001973141-23-000172 001-36407 231147685 33 4504
2023-08-04 4 PRIMARY DOCUMENT 0001735276-23-000071 21047
2023-08-03 10-Q 10-Q 0001178670-23-000015 001-36407 231138217 34 8222344 1 1
2023-08-03 8-K 8-K 2.02,5.02,9.01 0001193125-23-202313 001-36407 231138194 34 445038 1 1
2023-07-26 8-K 8-K 1.01,7.01,9.01 0001193125-23-194715 001-36407 231114534 34 199421 1 1
2023-06-30 8-K 8-K 8.01,9.01 0001193125-23-179631 001-36407 231059740 34 180352 1 1
2023-05-23 8-K 8-K 5.07,9.01 0001193125-23-151845 001-36407 23949303 34 161290 1 1
2023-05-19 4 PRIMARY DOCUMENT 0001735276-23-000068 5474
2023-05-19 4 PRIMARY DOCUMENT 0001735276-23-000067 5466
2023-05-19 4 PRIMARY DOCUMENT 0001735276-23-000066 9697
2023-05-19 4 PRIMARY DOCUMENT 0001735276-23-000065 5491
2023-05-19 4 PRIMARY DOCUMENT 0001735276-23-000064 9624
2023-05-19 4 PRIMARY DOCUMENT 0001735276-23-000063 5498
2023-05-19 4 PRIMARY DOCUMENT 0001735276-23-000062 5508
2023-05-19 4 PRIMARY DOCUMENT 0001735276-23-000061 5499
2023-05-19 4 PRIMARY DOCUMENT 0001735276-23-000060 9627
2023-05-19 4 PRIMARY DOCUMENT 0001735276-23-000059 9813
2023-05-04 10-Q 10-Q 0001178670-23-000011 001-36407 23886669 34 8083838 1 1
2023-05-04 8-K ALNYLAM PHARMACEUTICALS, INC. 8-K 2.02,9.01 0001157523-23-000728 001-36407 23886645 34 536790 1 1
2023-04-28 4 PRIMARY DOCUMENT 0001735276-23-000048 15289
2023-04-28 4 PRIMARY DOCUMENT 0001735276-23-000047 15248
2023-04-28 4 PRIMARY DOCUMENT 0001735276-23-000046 14343
2023-04-28 4 PRIMARY DOCUMENT 0001735276-23-000045 15228
2023-04-28 4 PRIMARY DOCUMENT 0001735276-23-000044 27056
2023-04-28 144 xsl144X01/primary_doc.xml 0001973141-23-000011 001-36407 23863484 33 5051
2023-04-10 4 PRIMARY DOCUMENT 0001735276-23-000038 4777
2023-04-03 ARS ARS 0001193125-23-089638 001-36407 23793291 34 9149257
2023-04-03 DEFA14A DEFA14A 0001193125-23-089620 001-36407 23793230 34 134668
2023-04-03 DEF 14A DEF 14A 0001193125-23-089611 001-36407 23793196 34 4561652 1 1
2023-03-09 4 PRIMARY DOCUMENT 0001735276-23-000036 5333
2023-03-09 3 PRIMARY DOCUMENT 0001735276-23-000035 7239
2023-03-08 8-K 8-K 5.02 0001193125-23-064580 001-36407 23716547 34 146969 1 1
2023-03-07 4 PRIMARY DOCUMENT 0001735276-23-000033 14055
2023-03-01 4 PRIMARY DOCUMENT 0001735276-23-000031 12857
2023-03-01 4 PRIMARY DOCUMENT 0001735276-23-000030 12792
2023-03-01 4 PRIMARY DOCUMENT 0001735276-23-000029 12857
2023-03-01 4 PRIMARY DOCUMENT 0001735276-23-000028 12804
2023-03-01 4 PRIMARY DOCUMENT 0001735276-23-000027 12842
2023-03-01 4 PRIMARY DOCUMENT 0001735276-23-000026 12844
2023-02-27 4 PRIMARY DOCUMENT 0001735276-23-000019 10853
2023-02-27 4 PRIMARY DOCUMENT 0001735276-23-000018 11711
2023-02-27 4 PRIMARY DOCUMENT 0001735276-23-000017 10854
2023-02-27 4 PRIMARY DOCUMENT 0001735276-23-000016 10857
2023-02-27 4 PRIMARY DOCUMENT 0001735276-23-000015 11734
2023-02-23 S-8 S-8 0001193125-23-046503 333-269939 23659533 33 88128
2023-02-23 10-K 10-K 0001178670-23-000005 001-36407 23656033 34 16582177 1 1
2023-02-23 8-K ALNYLAM PHARMACEUTICALS, INC. 8-K 2.02,9.01 0001157523-23-000344 001-36407 23656022 34 681216 1 1
2023-02-14 4 PRIMARY DOCUMENT 0001735276-23-000009 17050
2023-02-14 CT ORDER filename1.pdf 20230214,20230214 9999999997-23-000606 001-36407 23626027 34 133820
2023-02-14 SC 13G/A alny13gadec22.txt 0000080255-23-002573 005-79884 34 7205
2023-02-13 SC 13G/A SEC SCHEDULE 13G 0001422849-23-000032 005-79884 23617352 34 18391
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015258 005-79884 23602408 34 13132
2023-02-09 SC 13G/A filing.txt 0000315066-23-001402 005-79884 23601239 34 8408
2023-02-06 SC 13G/A SEC SCHEDULE 13G 0000846087-23-000069 005-79884 23590016 34 33896
2023-02-03 4 PRIMARY DOCUMENT 0001735276-23-000007 14228
2023-02-03 4 PRIMARY DOCUMENT 0001735276-23-000006 23478
2023-01-31 SC 13G/A us02043q1076_013123.txt 0001306550-23-005164 005-79884 23571844 34 13741
2023-01-19 SC 13G/A alnylam30122022.txt 0001088875-23-000022 005-79884 23536625 34 11304
2023-01-09 4 PRIMARY DOCUMENT 0001735276-23-000003 5236
2023-01-09 3 PRIMARY DOCUMENT 0001735276-23-000002 7079
2023-01-09 8-K FORM 8-K 2.02,9.01 0001193125-23-004109 001-36407 23516498 34 182394 1 1
2023-01-06 8-K 8-K 5.02,8.01,9.01 0001193125-23-003554 001-36407 23515271 34 180838 1 1
2022-12-07 4 PRIMARY DOCUMENT 0001735276-22-000078 15796
2022-11-23 4 PRIMARY DOCUMENT 0001735276-22-000076 12502
2022-10-27 10-Q 10-Q 0001178670-22-000026 001-36407 221334995 34 10339832 1 1
2022-10-27 8-K ALNYLAM PHARMACEUTICALS, INC. 8-K 2.02,9.01 0001157523-22-001411 001-36407 221334980 34 652525 1 1
2022-09-16 8-K 8-K 1.01,1.02,2.03,3.02,9.01 0001193125-22-246487 001-36407 221248752 34 1254253 1 1
2022-09-13 8-K 8-K 8.01,9.01 0001193125-22-243702 001-36407 221240807 34 201782 1 1
2022-09-09 SC 13G SEC SCHEDULE 13G 0001422849-22-000166 005-79884 221235523 34 18352
2022-08-24 8-K 8-K 5.02 0001193125-22-228534 001-36407 221191712 34 146593 1 1
2022-08-24 4 PRIMARY DOCUMENT 0001735276-22-000074 5235
2022-08-24 3 PRIMARY DOCUMENT 0001735276-22-000073 8016
2022-08-17 4 PRIMARY DOCUMENT 0001735276-22-000069 20502
2022-08-05 4 PRIMARY DOCUMENT 0001735276-22-000067 21195
2022-08-05 4 PRIMARY DOCUMENT 0001735276-22-000066 15480
2022-08-05 4 PRIMARY DOCUMENT 0001735276-22-000065 16633
2022-08-05 4 PRIMARY DOCUMENT 0001735276-22-000064 15462
2022-08-05 4 PRIMARY DOCUMENT 0001735276-22-000063 15521
2022-07-28 10-Q 10-Q 0001178670-22-000020 001-36407 221112916 34 8818351 1 1
2022-07-28 8-K ALNYLAM PHARMACEUTICALS, INC. 8-K 2.02,9.01 0001157523-22-000945 001-36407 221112891 34 623507 1 1
2022-07-07 4 PRIMARY DOCUMENT 0001735276-22-000057 4729
2022-06-14 8-K 8-K 8.01,9.01 0001193125-22-173444 001-36407 221013429 34 188720 1 1
2022-05-23 8-K 8-K 5.07,9.01 0001193125-22-157503 001-36407 22952142 34 161897 1 1
2022-05-20 4 PRIMARY DOCUMENT 0001735276-22-000055 5446
2022-05-20 4 PRIMARY DOCUMENT 0001735276-22-000054 5483
2022-05-20 4 PRIMARY DOCUMENT 0001735276-22-000053 5463
2022-05-20 4 PRIMARY DOCUMENT 0001735276-22-000052 5425
2022-05-20 4 PRIMARY DOCUMENT 0001735276-22-000051 5470
2022-05-20 4 PRIMARY DOCUMENT 0001735276-22-000050 5480
2022-05-20 4 PRIMARY DOCUMENT 0001735276-22-000049 5471
2022-05-20 4 PRIMARY DOCUMENT 0001735276-22-000048 5611
2022-04-28 10-Q 10-Q 0001178670-22-000016 001-36407 22862395 34 8428581 1 1
2022-04-28 8-K ALNYLAM PHARMACEUTICALS, INC. 8-K 2.02,9.01 0001157523-22-000494 001-36407 22862343 34 451170 1 1
2022-04-05 DEFA14A DEFA14A 0001193125-22-096193 001-36407 22807152 34 962985
2022-04-05 DEF 14A DEF 14A 0001193125-22-096188 001-36407 22807117 34 2591193
2022-04-05 8-K 8-K 5.02,9.01 0001193125-22-096176 001-36407 22807030 34 168433 1 1
2022-04-05 4 PRIMARY DOCUMENT 0001735276-22-000039 21861
2022-04-04 8-K 8-K 8.01,9.01 0001193125-22-094409 001-36407 22800380 34 170629 1 1
2022-03-17 8-K 8-K 8.01 0001193125-22-077831 001-36407 22746746 34 143485 1 1
2022-02-25 4 PRIMARY DOCUMENT 0001735276-22-000037 5872
2022-02-25 4 PRIMARY DOCUMENT 0001735276-22-000036 5848
2022-02-25 4 PRIMARY DOCUMENT 0001735276-22-000035 5815
2022-02-25 4 PRIMARY DOCUMENT 0001735276-22-000034 5791
2022-02-25 4 PRIMARY DOCUMENT 0001735276-22-000033 5850
2022-02-25 4 PRIMARY DOCUMENT 0001735276-22-000032 5553
2022-02-25 4 PRIMARY DOCUMENT 0001735276-22-000031 5562
2022-02-25 4 PRIMARY DOCUMENT 0001735276-22-000030 5545
2022-02-25 4 PRIMARY DOCUMENT 0001735276-22-000029 5552
2022-02-25 4 PRIMARY DOCUMENT 0001735276-22-000028 5528
2022-02-14 SC 13G alny13gdec21.txt 0000080255-22-002028 005-79884 34 6973

Latest XBRL company facts

One latest value per concept from companyfacts (456 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 133.94M 2026-10-23 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
dei EntityNumberOfEmployees Entity Number of Employees Employee 115 2012-01-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
dei EntityPublicFloat Entity Public Float USD 42.63B 2025-06-30 2025 FY 10-K 2026-02-12 0001628280-26-007497
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 2.99B 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001628280-26-023923
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 19.82M 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001628280-26-023923
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 6.58M 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001628280-26-023923
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 124.75 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001628280-26-023923
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 77.43M 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001628280-26-023923
ecd PeoTotalCompAmt PeoTotalCompAmt USD 14.87M 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001628280-26-023923
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 305.96 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001628280-26-023923
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 135.40M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 102.74M 2024-12-31 2024 FY 10-K 2025-02-13 0001178670-25-000026
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 1.08B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 0 2010-12-31 2010 FY 10-K 2011-02-18 0000950123-11-015737
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 1.24B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 34.33M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 322.70M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD 15.70M 2012-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -44.66M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 7.81B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 58,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-02 0001564590-19-015366
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 80.22M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD 120,000 2011-01-01 2011-12-31 2013 FY 10-K 2014-02-20 0001193125-14-060913
us-gaap AdvertisingExpense Advertising Expense USD 36.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 235.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 879,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap Assets Assets USD 7.99B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap AssetsCurrent Assets, Current USD 5.11B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 2.05B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 3.46M 2025-09-30 2025 Q3 10-Q 2025-10-30 0001628280-25-047345
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 94,000 2025-09-30 2025 Q3 10-Q 2025-10-30 0001628280-25-047345
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 1.26B 2025-09-30 2025 Q3 10-Q 2025-10-30 0001628280-25-047345
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 5,000 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-011031
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 2.07M 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-011031
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 303.26M 2013-03-31 2013 Q1 10-Q 2013-05-07 0001193125-13-204676
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 648,000 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-011031
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 648,000 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-011031
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 1.05B 2019-03-31 2019 Q1 10-Q 2019-05-02 0001564590-19-015366
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 1.05B 2019-03-31 2019 Q1 10-Q 2019-05-02 0001564590-19-015366
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 1.26B 2025-09-30 2025 Q3 10-Q 2025-10-30 0001628280-25-047345
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 1.83B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 13.92M 2017-12-31 2018 FY 10-K 2019-02-14 0001564590-19-003022
us-gaap AvailableForSaleSecuritiesEquitySecurities Available-for-sale Securities, Equity Securities USD 38.70M 2012-12-31 2013 FY 10-K 2014-02-20 0001193125-14-060913
us-gaap AvailableForSaleSecuritiesEquitySecuritiesCurrent Available-for-sale Securities, Equity Securities, Current USD 9.00M 2016-12-31 2017 FY 10-K 2018-02-15 0001564590-18-002152
us-gaap AvailableForSaleSecuritiesEquitySecuritiesNoncurrent Available-for-sale Securities, Equity Securities, Noncurrent USD 45.45M 2013-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap AvailableForSaleSecuritiesFairValueDisclosure Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) USD 303.02M 2013-03-31 2013 Q1 10-Q 2013-05-07 0001193125-13-204676
us-gaap AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments USD -1.89M 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-028070
us-gaap AvailableforsaleSecuritiesGrossUnrealizedGain Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) USD 27,000 2013-03-31 2013 Q1 10-Q 2013-05-07 0001193125-13-204676
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLosses1 Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) USD 260,000 2013-03-31 2013 Q1 10-Q 2013-05-07 0001193125-13-204676
us-gaap AvailableForSaleSecuritiesIncomeTaxExpenseOnChangeInUnrealizedHoldingGainOrLoss Available-for-sale Securities, Income Tax Expense on Change in Unrealized Holding Gain (Loss) (Deprecated 2018-01-31) USD -2.69M 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-20 0001193125-14-060913
us-gaap AvailableForSaleSecuritiesNoncurrent Available-for-sale Securities, Noncurrent USD 164.82M 2013-03-31 2013 Q1 10-Q 2013-05-07 0001193125-13-204676
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 29.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap CapitalizedContractCostNet Capitalized Contract Cost, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 1.75B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 44.21M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 451.74M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-15 0001564590-18-002152
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 1.76B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 1.49B 2025-09-30 2025 Q3 10-Q 2025-10-30 0001628280-25-047345
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -248.96M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-011031
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 97.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 80 2005-07-13 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 0.001 2005-07-13 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 250.00M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 133.88M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 133.88M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap CommonStockValue Common Stock, Value, Issued USD 1.34M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap CommonStockValueOutstanding Common Stock, Value, Outstanding USD 1.26M 2023-12-31 2023 FY 10-K 2024-02-15 0001178670-24-000008
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 2.51B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 260.98M 2018-12-31 2018 FY 10-K 2019-02-14 0001564590-19-003022
us-gaap ContractualObligation Contractual Obligation USD 4.59M 2018-12-31 2018 FY 10-K 2019-02-14 0001564590-19-003022
us-gaap ContractualObligationDueAfterFifthYear Contractual Obligation, to be Paid, after Year Five USD 525,000 2018-12-31 2018 FY 10-K 2019-02-14 0001564590-19-003022
us-gaap ContractualObligationDueInFifthYear Contractual Obligation, to be Paid, Year Five USD 525,000 2018-12-31 2018 FY 10-K 2019-02-14 0001564590-19-003022
us-gaap ContractualObligationDueInFourthYear Contractual Obligation, to be Paid, Year Four USD 545,000 2018-12-31 2018 FY 10-K 2019-02-14 0001564590-19-003022
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 1.45M 2018-12-31 2018 FY 10-K 2019-02-14 0001564590-19-003022
us-gaap ContractualObligationDueInSecondYear Contractual Obligation, to be Paid, Year Two USD 795,000 2018-12-31 2018 FY 10-K 2019-02-14 0001564590-19-003022
us-gaap ContractualObligationDueInThirdYear Contractual Obligation, to be Paid, Year Three USD 745,000 2018-12-31 2018 FY 10-K 2019-02-14 0001564590-19-003022
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 55.48M 2024-12-31 2024 FY 10-K 2025-02-13 0001178670-25-000026
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 11.67M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-02-13 0001178670-25-000026
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 4.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 361.53M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 651.09M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 867.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap CostsAndExpenses Costs and Expenses USD 3.07B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD 68.21M 2018-01-01 2019 FY 10-K 2020-02-13 0001178670-20-000004
us-gaap CumulativeEffectOnRetainedEarningsNetOfTax1 Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) USD 68.21M 2018-01-01 2018-03-31 2019 Q3 10-Q 2019-10-31 0001178670-19-000005
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 1.60M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-13 0001178670-25-000026
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 9.67M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 11.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 1.93M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.1 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-14 0001564590-19-003022
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001178670-24-000008
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD -2.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 2.01B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD 10.74M 2010-01-01 2010-12-31 2012 FY 10-K 2013-02-19 0001193125-13-065475
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -1.88B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 0 2019-12-31 2019 FY 10-K 2020-02-13 0001178670-20-000004
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 0 2019-12-31 2019 FY 10-K 2020-02-13 0001178670-20-000004
us-gaap DeferredRevenue Deferred Revenue USD 43.53M 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-011031
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 35.85M 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-011031
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 7.68M 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-011031
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 1.22M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap DeferredTaxAssetsDerivativeInstruments Deferred Tax Assets, Derivative Instruments USD 0 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap DeferredTaxAssetsEquityMethodInvestments Deferred Tax Assets, Equity Method Investments USD 1.62M 2016-12-31 2017 FY 10-K 2018-02-15 0001564590-18-002152
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 593.73M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 2.92B 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 12.14M 2018-12-31 2018 FY 10-K 2019-02-14 0001564590-19-003022
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 125.97M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 0 2010-12-31 2010 FY 10-K 2011-02-18 0000950123-11-015737
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 31.67M 2014-12-31 2015 FY 10-K 2016-02-12 0001193125-16-462538
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 987.12M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 90.62M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 2.47M 2017-12-31 2018 FY 10-K 2019-02-14 0001564590-19-003022
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 788,000 2015-12-31 2015 FY 10-K 2016-02-12 0001193125-16-462538
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax USD 394,000 2019-12-31 2019 FY 10-K 2020-02-13 0001178670-20-000004
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsForeign Deferred Tax Assets, Tax Credit Carryforwards, Foreign USD 3.20M 2016-12-31 2017 FY 10-K 2018-02-15 0001564590-18-002152
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsOther Deferred Tax Assets, Tax Credit Carryforwards, Other USD 788,000 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 452.26M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 69.98M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 2.73B 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap DeferredTaxLiabilitiesCurrent Deferred Tax Liabilities, Net, Current USD 31.67M 2014-12-31 2015 FY 10-K 2016-02-12 0001193125-16-462538
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 7,000 2013-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap DeferredTaxLiabilitiesInvestments Deferred Tax Liabilities, Investments USD 6.47M 2012-12-31 2013 FY 10-K 2014-02-20 0001193125-14-060913
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 41.81M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap DeferredTaxLiabilitiesOtherComprehensiveIncome Deferred Tax Liabilities, Other Comprehensive Income USD 0 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 17.37M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap Depreciation Depreciation USD 54.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap DepreciationAmortizationAndAccretionNet Depreciation, Amortization and Accretion, Net USD 41.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 3.18M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-011031
us-gaap DerivativeLiabilities Derivative Liability USD 486.92M 2024-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 0 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 19.02 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.71 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-04-29 0001178670-21-000017
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 18.42 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.029 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.029 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-13 0001178670-20-000004
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.027 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap EffectiveIncomeTaxRateReconciliationGiltiAmount EffectiveIncomeTaxRateReconciliationGiltiAmount USD 86.24M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap EffectiveIncomeTaxRateReconciliationGiltiPercent EffectiveIncomeTaxRateReconciliationGiltiPercent pure 0.267 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.007 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.281 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.013 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.007 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0.059 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.042 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-14 0001564590-19-003022
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsInvestment Effective Income Tax Rate Reconciliation, Tax Credit, Investment, Percent pure -0.075 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.086 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD -29,000 2010-01-01 2010-12-31 2012 FY 10-K 2013-02-19 0001193125-13-065475
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -10.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap EffectOnFutureEarningsOffsetAmount Effect on Future Earnings, Offset Amount USD 20.00M 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-05 0001193125-12-452123
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 257.20M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount Share-based Payment Arrangement, Amount Capitalized USD 3.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 31.80M 2013-12-31 2013 FY 10-K 2014-02-20 0001193125-14-060913
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.12 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap EquityMethodInvestments Equity Method Investments USD -2.75M 2012-09-30 2012 Q3 10-Q 2012-11-05 0001193125-12-452123
us-gaap EquityMethodInvestmentSummarizedFinancialInformationAssets Equity Method Investment, Summarized Financial Information, Assets (Deprecated 2020-01-31) USD 42.88M 2011-12-31 2012 FY 10-K 2013-02-19 0001193125-13-065475
us-gaap EquityMethodInvestmentSummarizedFinancialInformationCostOfSales Equity Method Investment, Summarized Financial Information, Cost of Sales (Deprecated 2020-01-31) USD 17.73M 2012-01-01 2012-09-30 2013 FY 10-K 2014-02-20 0001193125-14-060913
us-gaap EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets Equity Method Investment, Summarized Financial Information, Current Assets (Deprecated 2020-01-31) USD 38.67M 2011-12-31 2012 FY 10-K 2013-02-19 0001193125-13-065475
us-gaap EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities Equity Method Investment, Summarized Financial Information, Current Liabilities (Deprecated 2020-01-31) USD 12.85M 2011-12-31 2012 FY 10-K 2013-02-19 0001193125-13-065475
us-gaap EquityMethodInvestmentSummarizedFinancialInformationEquity Equity Method Investment Summarized Financial Information, Equity (Deprecated 2020-01-31) USD -6.43M 2012-09-30 2012 Q3 10-Q 2012-11-05 0001193125-12-452123
us-gaap EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31) USD -8.27M 2012-01-01 2012-09-30 2013 FY 10-K 2014-02-20 0001193125-14-060913
us-gaap EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) USD -10.53M 2012-01-01 2012-09-30 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities Equity Method Investment, Summarized Financial Information, Noncurrent Liabilities (Deprecated 2020-01-31) USD 28.83M 2011-12-31 2012 FY 10-K 2013-02-19 0001193125-13-065475
us-gaap EquityMethodInvestmentSummarizedFinancialInformationRevenue Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) USD 9.46M 2012-01-01 2012-09-30 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap EquitySecuritiesFvNi Equity Securities, FV-NI USD 0 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap EquitySecuritiesFvNiGainLoss Equity Securities, FV-NI, Gain (Loss) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap EquitySecuritiesFvNiUnrealizedGainLoss Equity Securities, FV-NI, Unrealized Gain (Loss) USD 69.64M 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-06 0001178670-20-000015
us-gaap ExcessTaxBenefitFromShareBasedCompensationOperatingActivities Excess Tax Benefit from Share-based Compensation, Operating Activities USD -120,000 2011-01-01 2011-12-31 2013 FY 10-K 2014-02-20 0001193125-14-060913
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2020-06-30 2020 Q2 10-Q 2020-08-06 0001178670-20-000015
us-gaap FairValueEquityLevel2ToLevel1TransfersAmount Fair Value, Equity, Level 2 to Level 1 Transfers, Amount USD 0 2014-03-31 2014 Q1 10-Q 2014-05-09 0001193125-14-192579
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-10-31 0001178670-24-000053
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-10-31 0001178670-24-000053
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD -40.21M 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-15 0001564590-17-001649
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 145,000 2012-09-30 2012 Q3 10-Q 2012-11-05 0001193125-12-452123
us-gaap ForeignIncomeTaxExpenseBenefitContinuingOperations Foreign Income Tax Expense (Benefit), Continuing Operations USD -34,000 2013-01-01 2013-12-31 2015 FY 10-K 2016-02-12 0001193125-16-462538
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 7.24M 2018-12-31 2018 FY 10-K 2019-02-14 0001564590-19-003022
us-gaap GainContingencyPatentsFoundNotInfringedUponNumber Gain Contingency, Patents Found Not Infringed upon, Number patent 2 2023-01-01 2023-12-31 2025 Q2 10-Q 2025-07-31 0001178670-25-000090
us-gaap GainContingencyUnrecordedAmount Gain Contingency, Unrecorded Amount USD 8.00M 2015-10-14 2017 FY 10-K 2018-02-15 0001564590-18-002152
us-gaap GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome Gain (Loss) on Sale of Previously Unissued Stock by Subsidiary or Equity Investee, Nonoperating Income USD 16.08M 2012-01-01 2012-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-13 0001178670-20-000004
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 157.13M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-02 0001564590-18-018696
us-gaap ImpairmentOfInvestments Other than Temporary Impairment Losses, Investments USD 1.56M 2008-01-01 2008-12-31 2010 FY 10-K 2011-02-18 0000950123-11-015737
us-gaap IncentiveFromLessor Incentive from Lessor USD 2.10M 2016-12-31 2016 FY 10-K 2017-02-15 0001564590-17-001649
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 18.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 695.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 304.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -855.60M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-11 0001178670-21-000010
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD -4.52M 2012-01-01 2012-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap IncomeTaxesPaid Income Taxes Paid USD 2.57M 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-13 0001178670-20-000004
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 29.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 0 2011-12-31 2011 FY 10-K 2012-02-13 0001193125-12-053552
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -1.84B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap IncomeTaxExpenseBenefitIntraperiodTaxAllocation Income Tax Expense (Benefit), Intraperiod Tax Allocation USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-15 0001564590-18-002152
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 9.37M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 67.86M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 2.15M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD -90.69M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -4.11M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -2.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 18.99M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 27.65M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -3.72M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-10-31 0001178670-19-000005
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -18.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 313.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD -5.52M 2010-01-01 2010-12-31 2012 FY 10-K 2013-02-19 0001193125-13-065475
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 6.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -2.89M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-02 0001564590-18-018696
us-gaap IncreaseDecreaseInIncomeTaxesReceivable Increase (Decrease) in Income Taxes Receivable USD -10.67M 2011-01-01 2011-12-31 2013 FY 10-K 2014-02-20 0001193125-14-060913
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 2.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -37.84M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-10-31 0001178670-24-000053
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 36.35M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-10-31 0001178670-19-000005
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 102.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD -31.04M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-02 0001564590-18-018696
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 288,000 2015-01-01 2015-03-31 2016 Q1 10-Q 2016-05-04 0001193125-16-577773
us-gaap IncreaseDecreaseInRestrictedCashAndInvestments Increase (Decrease) in Restricted Cash and Investments USD 150.00M 2016-01-01 2016-12-31 2017 FY 10-K 2018-02-15 0001564590-18-002152
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 2.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap InducedConversionOfConvertibleDebtExpense Induced Conversion of Convertible Debt Expense USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap InterestExpense Interest Expense USD 35.25M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-02 0001178670-24-000023
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 235.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap InterestOnConvertibleDebtNetOfTax Interest on Convertible Debt, Net of Tax USD 3.52M 2023-07-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0001178670-23-000023
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 2.43M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-15 0001564590-18-002152
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 195.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 40.42M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap InventoryNet Inventory, Net USD 105.91M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 11.30M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 18.02M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 58.80M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 85.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap InvestmentIncomeNet Investment Income, Net USD 5.48M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-06 0001178670-20-000007
us-gaap InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures USD 564,000 2011-12-31 2012 Q3 10-Q 2012-11-05 0001193125-12-452123
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 3.20M 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-20 0001193125-14-060913
us-gaap Land Land USD 9.08M 2018-12-31 2018 FY 10-K 2019-02-14 0001564590-19-003022
us-gaap LeaseCost Lease, Cost USD 74.37M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 65.93M 2018-12-31 2018 FY 10-K 2019-02-14 0001564590-19-003022
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 366.28M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 136.38M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 48.07M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 41.78M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 42.99M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 44.31M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 52.75M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 8.22M 2019-09-30 2019 Q3 10-Q 2019-10-31 0001178670-19-000005
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 95.67M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap Liabilities Liabilities USD 4.39B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 7.99B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap LiabilitiesCurrent Liabilities, Current USD 2.06B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap LicenseAndServicesRevenue License and Services Revenue (Deprecated 2018-01-31) USD 21.90M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-011031
us-gaap LongTermDebt Long-term Debt USD 677.72M 2022-06-30 2022 Q2 10-Q 2022-07-28 0001178670-22-000020
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 43.43M 2018-12-31 2018 FY 10-K 2019-02-14 0001564590-19-003022
us-gaap MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss USD -595,000 2011-01-01 2011-09-30 2012 Q3 10-Q 2012-11-05 0001193125-12-452123
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD 511,000 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-13 0001193125-12-053552
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 70.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 41.52M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-011031
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -700.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -134.81M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-011031
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 738.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -155.66M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-011031
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 2.54B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD 2.54B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap NetRentableArea Net Rentable Area sqft 129,000 2012-12-31 2012 FY 10-K 2013-02-19 0001193125-13-065475
us-gaap NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 Noncash or Part Noncash Acquisition, Value of Assets Acquired USD 195.77M 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-15 0001564590-17-001649
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -150.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap OciBeforeReclassificationsNetOfTaxAttributableToParent OCI, before Reclassifications, Net of Tax, Attributable to Parent USD -19.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap OperatingExpenses Operating Expenses USD 391.56M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-02 0001564590-18-018696
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 845.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap OperatingLeaseCost Operating Lease, Cost USD 49.82M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 61.60M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001178670-24-000008
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 270.61M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 46.08M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 203.29M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap OperatingLeasePayments Operating Lease, Payments USD 50.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 177.95M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 562.01M 2018-12-31 2019 FY 10-K 2020-02-13 0001178670-20-000004
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 32.23M 2018-12-31 2019 FY 10-K 2020-02-13 0001178670-20-000004
us-gaap OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals USD 10.00M 2012-12-31 2012 FY 10-K 2013-02-19 0001193125-13-065475
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 35.27M 2018-12-31 2019 FY 10-K 2020-02-13 0001178670-20-000004
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 34.83M 2018-12-31 2019 FY 10-K 2020-02-13 0001178670-20-000004
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 34.41M 2018-12-31 2019 FY 10-K 2020-02-13 0001178670-20-000004
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 34.83M 2018-12-31 2019 FY 10-K 2020-02-13 0001178670-20-000004
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 390.45M 2018-12-31 2019 FY 10-K 2020-02-13 0001178670-20-000004
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 52.40M 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-13 0001178670-20-000004
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.08 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 25.57M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 60.31M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent USD -267,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax (Deprecated 2012-01-31) USD -29,000 2010-01-01 2010-12-31 2011 FY 10-K 2012-02-13 0001193125-12-053552
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) USD -29,000 2010-01-01 2010-12-31 2011 FY 10-K 2012-02-13 0001193125-12-053552
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD -5.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD -4.08M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-01 0001178670-25-000052
us-gaap OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax Other Comprehensive Income (Loss), before Reclassifications, Net of Tax USD 8.35M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0001178670-23-000023
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -29,000 2010-01-01 2010-12-31 2012 FY 10-K 2013-02-19 0001193125-13-065475
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -3.00M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-01 0001178670-25-000052
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -24.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax USD -55,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-01 0001178670-25-000052
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-13 0001178670-20-000004
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -19.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax USD -10.60M 2012-01-01 2012-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 10.61M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -521,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-07 0001193125-15-282067
us-gaap OtherNoncashIncomeTaxExpense Other Noncash Income Tax Expense USD -216,000 2010-01-01 2010-06-30 2011 Q2 10-Q 2011-08-03 0000950123-11-071950
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -579,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap OtherOperatingActivitiesCashFlowStatement Other Operating Activities, Cash Flow Statement USD 7.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap OtherPostretirementBenefitsPayments Payment for Other Postretirement Benefits USD -96,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-03 0001193125-12-208797
us-gaap OtherRestructuringCosts Other Restructuring Costs USD 3.90M 2012-01-01 2012-03-31 2012 FY 10-K 2013-02-19 0001193125-13-065475
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net USD 595,000 2011-01-01 2011-12-31 2013 FY 10-K 2014-02-20 0001193125-14-060913
us-gaap PaymentsForCapitalImprovements Payments for Capital Improvements USD 9.06M 2016-01-01 2016-03-31 2017 Q1 10-Q 2017-05-05 0001564590-17-008948
us-gaap PaymentsForPreviousAcquisition Payments for Previous Acquisition USD 44.30M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0001178670-23-000005
us-gaap PaymentsForProceedsFromDerivativeInstrumentFinancingActivities Payments for (Proceeds from) Derivative Instrument, Financing Activities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 27.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap PaymentsForProceedsFromTenantAllowance Payments for (Proceeds from) Tenant Allowance USD -5.55M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-11 0001178670-21-000010
us-gaap PaymentsForRepurchaseOfCommonStockForEmployeeTaxWithholdingObligations Payments for Repurchase of Common Stock for Employee Tax Withholding Obligations (Deprecated 2013-01-31) USD 328,000 2012-01-01 2012-03-31 2013 Q1 10-Q 2013-05-07 0001193125-13-204676
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 5.60M 2019-01-01 2019-01-31 2021 FY 10-K 2022-02-10 0001178670-22-000013
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 84,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-06 0001564590-19-029367
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 364.31M 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-20 0001193125-14-060913
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 1.35B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 25.00M 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-15 0001564590-17-001649
us-gaap PaymentsToAcquireInterestInJointVenture Payments to Acquire Interest in Joint Venture USD 10.00M 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-13 0001193125-12-053552
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 126.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap PaymentsToAcquireRestrictedInvestments Payments to Acquire Restricted Investments USD 22.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap PensionAndOtherPostretirementBenefitExpense Pension and Other Postretirement Benefits Cost (Reversal of Cost) USD 3.27M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-10-31 0001178670-19-000005
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap PreferredStockValueOutstanding Preferred Stock, Value, Outstanding USD 0 2023-12-31 2023 FY 10-K 2024-02-15 0001178670-24-000008
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 334.60M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap ProceedsFromDerivativeInstrumentFinancingActivities Proceeds from Derivative Instrument, Financing Activities USD 1.77M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-01 0001178670-24-000041
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-10 0001178670-22-000013
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-07-28 0001178670-22-000020
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0001178670-23-000005
us-gaap ProceedsFromIssuanceOfSecuredDebt Proceeds from Issuance of Secured Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0001178670-23-000005
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 62.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 993,000 2010-01-01 2010-12-31 2012 FY 10-K 2013-02-19 0001193125-13-065475
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-10-27 0001178670-22-000026
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD -16,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap ProceedsFromRepaymentsOfSecuredDebt Proceeds from (Repayments of) Secured Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-13 0001178670-25-000026
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 244.88M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-04 0001564590-18-011031
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 753.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap ProceedsFromSaleOfRestrictedInvestments Proceeds from Sale of Restricted Investments USD 68.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -1.13B 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0001178670-23-000005
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 835.85M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 614.91M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap PropertyPlantAndEquipmentOther Property, Plant and Equipment, Other, Gross USD 28.56M 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap PurchaseObligation Purchase Obligation USD 150.20M 2015-12-31 2015 FY 10-K 2016-02-12 0001193125-16-462538
us-gaap PurchaseObligationDueInNextTwelveMonths Purchase Obligation, to be Paid, Year One USD 87.50M 2015-12-31 2015 FY 10-K 2016-02-12 0001193125-16-462538
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 2.96M 2018-06-30 2018 Q2 10-Q 2018-08-02 0001564590-18-018696
us-gaap ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD -3.97M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0001178670-23-000023
us-gaap ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent USD 4.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap RepaymentsOfDebt Repayments of Debt USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0001178670-23-000023
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001178670-20-000019
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 6.76M 2008-01-01 2008-12-31 2010 FY 10-K 2011-02-18 0000950123-11-015737
us-gaap RepaymentsOfSecuredDebt Repayments of Secured Debt USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-11 0001178670-21-000010
us-gaap ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff Research and Development Asset Acquired Other than Through Business Combination, Written-off USD 220.77M 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-15 0001564590-17-001649
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 1.19B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap RestrictedCash Restricted Cash USD 2.55M 2025-09-30 2025 Q3 10-Q 2025-10-30 0001628280-25-047345
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 2.14M 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-028070
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 1.56M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 1.48M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap RestrictedInvestmentsNoncurrent Restricted Investments, Noncurrent USD 22.17M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap RestrictedStockExpense Restricted Stock or Unit Expense USD 3.40M 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-20 0001193125-14-060913
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.33 2012-01-01 2012-01-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap RestructuringCharges Restructuring Charges USD 3.90M 2012-01-01 2012-03-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap RestructuringReserve Restructuring Reserve USD 356,000 2012-09-30 2012 Q3 10-Q 2012-11-05 0001193125-12-452123
us-gaap RestructuringReserveAccrualAdjustment Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) USD 0 2012-07-01 2012-09-30 2012 Q3 10-Q 2012-11-05 0001193125-12-452123
us-gaap RestructuringReserveSettledWithCash Restructuring Reserve, Settled With Cash (Deprecated 2013-01-31) USD 767,000 2012-07-01 2012-09-30 2012 Q3 10-Q 2012-11-05 0001193125-12-452123
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -4.16B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 3.92B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap Revenues Revenues USD 1.04B 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0001178670-23-000005
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 457,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap SaleOfStockConsiderationReceivedPerTransaction Sale of Stock, Consideration Received Per Transaction USD 10.00M 2009-03-01 2009-03-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 20.90M 2011-01-01 2011-03-31 2011 Q1 10-Q 2011-05-05 0000950123-11-045184
us-gaap SecuredLongTermDebt Secured Long-term Debt, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-02-23 0001178670-23-000005
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 1.01B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 235.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 Share-based Payment Arrangement, Expensed and Capitalized, Amount USD 239.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 29,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 68.28 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 30,000 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 68.02 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 499,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 10.59 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-13 0001178670-20-000004
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.57 2012-01-01 2012-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.66 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-13 0001178670-20-000004
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.63 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-13 0001178670-20-000004
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.026 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-13 0001178670-20-000004
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.014 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-13 0001178670-20-000004
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 15.56M 2017-12-31 2017 FY 10-K 2018-02-15 0001564590-18-002152
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 357.89M 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 4.74M 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 21.44 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 126.50M 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 85,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 1.35M 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 8.68 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 478.51M 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 7.53M 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 33.46 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 12.82 2012-12-31 2012 FY 10-K 2013-02-19 0001193125-13-065475
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 470.15M 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 7.29M 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 32.53 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 14.83 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 35.32 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 75.77 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionExpense Share-based Goods and Nonemployee Services Transaction, Expense (Deprecated 2013-01-31) USD 1.00M 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-19 0001193125-13-065475
us-gaap SharePrice Share Price USD/shares 478.63 2025-09-09 2025 Q3 10-Q 2025-10-30 0001628280-25-047345
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 77.5 2019-01-31 2021 FY 10-K 2022-02-10 0001178670-22-000013
us-gaap StockGrantedDuringPeriodValueSharebasedCompensationGross Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture USD 16.68M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-13 0001193125-12-053552
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 3.60B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 158.23M 2010-12-31 2010 FY 10-K 2011-02-18 0000950123-11-015737
us-gaap StockholdersEquityPeriodIncreaseDecrease Stockholders' Equity, Period Increase (Decrease) USD -288.30M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-028070
us-gaap StockIssued1 Stock Issued USD 51.45M 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-15 0001564590-17-001649
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 5.00M 2019-01-01 2019-01-31 2021 FY 10-K 2022-02-10 0001178670-22-000013
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures shares 508,928 2012-01-01 2012-01-31 2012 Q3 10-Q 2012-11-05 0001193125-12-452123
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 1.98M 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap StockIssuedDuringPeriodValueEmployeeBenefitPlan Stock Issued During Period, Value, Employee Benefit Plan USD 99.50M 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-23 0001178670-23-000005
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 99.50M 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-10 0001178670-22-000013
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 784,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-02 0001564590-19-015366
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 195.77M 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-15 0001564590-17-001649
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 2.30M 2011-05-01 2011-05-31 2015 FY 10-K 2016-02-12 0001193125-16-462538
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD -519,000 2012-01-01 2012-12-31 2014 FY 10-K 2015-02-13 0001193125-15-050223
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 0 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 14.70M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap TaxAdjustmentsSettlementsAndUnusualProvisions Tax Adjustments, Settlements, and Unusual Provisions USD 20.68M 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-15 0001564590-17-001649
us-gaap UndistributedEarningsOfForeignSubsidiaries Undistributed Earnings of Foreign Subsidiaries USD 86.20M 2024-12-31 2024 FY 10-K 2025-02-13 0001178670-25-000026
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 77.97M 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 128,000 2012-01-01 2012-12-31 2013 FY 10-K 2014-02-20 0001193125-14-060913
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities USD 1.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-10 0001178670-22-000013
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 10.46M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 9.47M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2018-12-31 2018 FY 10-K 2019-02-14 0001564590-19-003022
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 1.95B 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap ValuationAllowancesAndReservesBalance SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount USD 556.97M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap VariableInterestEntityEntityMaximumLossExposureAmount Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount USD 5.60M 2012-09-30 2012 Q3 10-Q 2012-11-05 0001193125-12-452123
us-gaap VariableLeaseCost Variable Lease, Cost USD 24.55M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001628280-26-007497
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 138.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 117.08M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-04-29 0001178670-21-000017
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 133.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001178670-26-000076
us-gaap WeightedAverageNumberOfSharesOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) shares 42.38M 2011-06-30 2011 Q2 10-Q 2011-08-03 0000950123-11-071950

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →